Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EBI-005 in moderate to severe dry eye disease
NCT01998802Phase 3Completed
- Sponsor
- Sesen Bio
- Start
- Jan 2014
- Primary completion
- Mar 2015
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of isunakinra in dry eye disease (DED), sponsored by Sesen Bio. Started Jan 2014; status: completed.
02
Drugs
isunakinra
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT01998802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01998802.